FREEMAN KEVIN D

Average Profitability
0.09%
Insider Buys Quantity
28
Insider Buys Sum
$332,476.07
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of FREEMAN KEVIN D

According to the SEC Form 4 filings, FREEMAN KEVIN D, being in a position of

  1. director at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 16300 shares for $43,832, and sold 0 shares,
    over all time since 2013-05-28, has bought 128692 shares for $332,476, and sold 0 shares.

The largest purchase of all time was on 2019-05-31 and amounted to 9136 shares of Galectin Therapeutics Inc. for $39,102.

Biography of FREEMAN KEVIN D

No biography is available at this moment.

2024-10-17PurchaseGalectin Therapeutics Inc.
GALT
director
1,300
0.0021%
$2.64$3,432+3.2%
2024-10-16PurchaseGalectin Therapeutics Inc.
GALT
director
10,000
0.0164%
$2.70$27,000+3.42%
2024-06-20PurchaseGalectin Therapeutics Inc.
GALT
director
2,500
0.0037%
$2.38$5,950+6.61%
2024-04-22PurchaseGalectin Therapeutics Inc.
GALT
director
2,500
0.0039%
$2.98$7,450-11.31%
2022-10-28PurchaseGalectin Therapeutics Inc.
GALT
director
10,000
0.0171%
$1.41$14,100+16.55%
2022-05-19PurchaseGalectin Therapeutics Inc.
GALT
5,000
0.0085%
$1.33$6,650+23.48%
2022-04-18PurchaseGalectin Therapeutics Inc.
GALT
5,000
0.0086%
$1.71$8,550-7.74%
2022-01-19PurchaseGalectin Therapeutics Inc.
GALT
5,000
0.0082%
$1.96$9,806-19.9%
2021-12-15PurchaseGalectin Therapeutics Inc.
GALT
5,000
0.0085%
$2.28$11,400-25.33%
2021-12-06PurchaseGalectin Therapeutics Inc.
GALT
director
10,000
0.0165%
$2.31$23,100-27.75%
2021-10-29PurchaseGalectin Therapeutics Inc.
GALT
2,000
0.0034%
$3.17$6,340-42.9%
2021-10-21PurchaseGalectin Therapeutics Inc.
GALT
2,000
0.0033%
$3.19$6,380-43.17%
2021-10-19PurchaseGalectin Therapeutics Inc.
GALT
3,000
0.0051%
$3.37$10,107-44.88%
2021-09-23PurchaseGalectin Therapeutics Inc.
GALT
3,000
0.005%
$3.88$11,631-51.64%
2021-04-05PurchaseGalectin Therapeutics Inc.
GALT
director
5,000
0.0085%
$2.04$10,200+41.79%
2020-09-04PurchaseGalectin Therapeutics Inc.
GALT
director
5,000
0.0085%
$2.57$12,848+1.51%
2020-03-19PurchaseGalectin Therapeutics Inc.
GALT
director
6,000
0.0105%
$1.64$9,844+59.09%
2019-11-15PurchaseGalectin Therapeutics Inc.
GALT
director
3,000
0.0055%
$3.36$10,076-15.48%
2019-09-06PurchaseGalectin Therapeutics Inc.
GALT
director
1,290
0.0022%
$3.71$4,786-24.54%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
director
9,136
0.0193%
$4.28$39,102-23.33%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.